• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Body disappearance and liver mean transit time of 99m-Tc-diethyl-IDA.

作者信息

Taavitsainen M, Riihimäki E, Tähti E

出版信息

Eur J Nucl Med. 1980 Apr;5(2):147-50. doi: 10.1007/BF00252475.

DOI:10.1007/BF00252475
PMID:7379817
Abstract

The body disappearances and the liver mean transit times of a hepatobiliary tracer, 99mTc-diethyl IDA, were measured from 100 cholescintigraphies of 98 patients. Fifteen patients had no hepatobiliary disease; their mean body disappearance was 6.6, SD 1.1%/min, and mean liver mean transit time 32, SD 19 min. The values within 2 SDs, disappearance greater than or equal to 4.4%/min and mean transit time less than or equal to 70 min, were used as reference values. Disappearance constants below 4.4%/min were observed 29% and mean transit times exceeding 70 min in 49% of the examinations performed on patients with some hepatobiliary abnormality. The calculated parameters were compared with the levels of serum bilirubin and ASAT. Disappearance constants below 4.4%/min were seen in 33% and mean transit times exceeding 70 min in 55% of the patients who had either abnormal serum bilirubin or ASAT due to a hepatobiliary disease. The correlation between the serum bilirubin and the disappearance was -0.13, and between ASAT and body disappearance it was -0.28. The corresponding correlation coefficients of serum bilirubin and ASAT with the liver mean transit times were 0.33 and 0.44. Long mean transit times in relation to bilirubin and ASAT were seen in some acute cases. Short mean transit times in relation to bilirubin and ASAT were seen with falling serum levels of the latter.

摘要

相似文献

1
Body disappearance and liver mean transit time of 99m-Tc-diethyl-IDA.
Eur J Nucl Med. 1980 Apr;5(2):147-50. doi: 10.1007/BF00252475.
2
A crossover study comparing the kinetics of Tc-99m-labeled diethyl- and diisopropyl-IDA.一项比较锝-99m标记的二乙基和二异丙基亚氨基二乙酸动力学的交叉研究。
Clin Nucl Med. 1980 Aug;5(8):352-8. doi: 10.1097/00003072-198008000-00004.
3
Relative role of Tc-99m-diethyl-IDA and Tc-99m-sulfur colloid in the evaluation of liver function.
Clin Nucl Med. 1980 Aug;5(8):341-6. doi: 10.1097/00003072-198008000-00001.
4
Clinical comparison of diisopropyl-IDA Tc 99m and diethyl-IDA Tc 99m for evaluation of the hepatobiliary system.99m锝二异丙基-IDA和99m锝二乙基-IDA用于评估肝胆系统的临床比较。
Radiology. 1981 Sep;140(3):791-5. doi: 10.1148/radiology.140.3.7197041.
5
Comparative quantitative evaluation of hepatic clearance of diethyl-IDA and para-butyl-IDA in jaundiced and non-jaundiced patients.黄疸和非黄疸患者中乙二胺二乙酸(diethyl - IDA)和对丁基乙二胺二乙酸(para - butyl - IDA)肝脏清除率的比较定量评估
Eur J Nucl Med. 1981 Dec;6(12):539-43. doi: 10.1007/BF00252666.
6
Hepatic clearance mechanism of Tc-99m-N-(acetanilido)-iminodiacetic acid derivatives.锝-99m-N-(乙酰苯胺基)-亚氨基二乙酸衍生物的肝脏清除机制
J Nucl Med. 1980 Nov;21(11):1110-2.
7
[Hepatobiliary and renal excretion of Rotop-EHIDA--animal experimental studies].[放射性核素肝胆显像剂(罗托 - 依替膦二钠)的肝胆及肾脏排泄——动物实验研究]
Radiobiol Radiother (Berl). 1983;24(1):95-101.
8
The influence of bilirubin, alcohol and certain drugs on the kinetics of 99mTc-Diethyl IDA (EHIDA) in humans.胆红素、酒精及某些药物对99m锝-二乙基亚氨基二乙酸(EHIDA)在人体动力学的影响。
Eur J Nucl Med. 1983;8(4):140-4. doi: 10.1007/BF00252882.
9
A mathematical model for the liver uptake and excretion of 99mTc-diethyl IDA.99mTc-二乙基亚氨基二乙酸肝脏摄取与排泄的数学模型。
Eur J Nucl Med. 1981 Apr;6(4):139-42. doi: 10.1007/BF00253161.
10
Clinical comparison of 99mTc-diethyl-IDA and 99mTc-PIPIDA for evaluation of the hepatobiliary system.
Radiology. 1980 Jan;134(1):195-9. doi: 10.1148/radiology.134.1.7350605.

引用本文的文献

1
The use of 99m Tc-Diethyl-IDA as a liver function test.使用99m锝 - 二乙基亚氨基二乙酸作为肝功能测试。
Eur J Nucl Med. 1980 Dec;5(6):537. doi: 10.1007/BF00252046.
2
A practical approach to the hepatobiliary kinetics of 99mTc-HIDA. Clinical validation of the method and a preliminary report on its use for parametric imaging.99mTc-HIDA肝胆动力学的实用方法。该方法的临床验证及其用于参数成像的初步报告。
Eur J Nucl Med. 1983;8(7):292-8. doi: 10.1007/BF00253754.

本文引用的文献

1
The radioactive (I131 tagged) rose bengal uptake-excretion test for liver function using external gamma-ray scintillation counting techniques.使用外部γ射线闪烁计数技术的放射性(I131标记)孟加拉玫瑰红摄取-排泄肝功能试验。
J Lab Clin Med. 1955 May;45(5):665-78.
2
Measurement of the mean transit time of cerebral circulation by external detection of an intravenously injected radioisotope.通过静脉注射放射性同位素的外部检测来测量脑循环的平均通过时间。
J Nucl Med. 1962 Sep;3:382-98.
3
1-131-rose bengal test of liver function. A clinical evaluation.
肝功能的131碘-玫瑰红试验。临床评估。
Gastroenterology. 1959 Dec;37:725-34.
4
Application of the modified gamma function to the calculation of cardiopulmonary blood pools in radiocardiography.修正伽马函数在放射性心动描记术中计算心肺血池的应用。
Phys Med Biol. 1974 Sep;19(5):692-700. doi: 10.1088/0031-9155/19/5/009.
5
Estimation of the functional reserve of human liver.人体肝脏功能储备的评估。
Ann Surg. 1974 Oct;180(4):592-8. doi: 10.1097/00000658-197410000-00024.
6
131I Rose Bengal scanning and clearance ratios in the investigation of jaundiced patients.
Clin Radiol. 1976 Apr;27(2):227-35. doi: 10.1016/s0009-9260(76)80150-x.
7
Sequential liver and biliary tract scanning with 131I labelled Rose Bengal.用131I标记的玫瑰红进行肝脏和胆道的连续扫描。
Clin Radiol. 1975 Oct;26(4):499-504. doi: 10.1016/s0009-9260(75)80110-3.
8
Quantitative liver imaging using 131-I Rose Bengal as an index of liver function and prognosis.以131-I 玫瑰红作为肝功能和预后指标的定量肝脏成像。
Gut. 1975 Sep;16(9):738-43. doi: 10.1136/gut.16.9.738.
9
The value of the radio-isotope hepatogram in the jaundiced patient.放射性同位素肝扫描在黄疸患者中的价值。
Br J Surg. 1975 Oct;62(10):781-7. doi: 10.1002/bjs.1800621009.
10
Technetium-99m-pyridoxylideneglutamate: a new hepatobiliary radiopharmaceutical. II. Clinical aspects.锝-99m-吡哆醛谷氨酸:一种新型肝胆放射性药物。II. 临床方面。
J Nucl Med. 1975 Aug;16(8):728-37.